ATROMID S CAP 500MG DIN 00002038
Health Canada record
| Active ingredient(s) | CLOFIBRATE 500 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C10AB01 CLOFIBRATE |
| Original market date | 31-Dec-1968 |
| Current status date | 15-Aug-1997 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CLOFIBRATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02041499 | ATROMID-S 1GM | WYETH-AYERST CANADA INC. | Capsule | CLOFIBRATE 1 G | Cancelled Post Market |
| 02041480 | ATROMID-S CAP 500MG | WYETH-AYERST CANADA INC. | Capsule | CLOFIBRATE 500 MG | Cancelled Post Market |
| 00337382 | NOVO-FIBRATE CAP 500MG | NOVOPHARM LIMITED | Capsule | CLOFIBRATE 500 MG | Cancelled Post Market |
International API supply for CLOFIBRATE
0 active FDA Drug Master Files.
Request a quote for ATROMID S CAP 500MG